Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

424
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
424
Theory of Attribution I: Correspondent Inference Theory01:15

Theory of Attribution I: Correspondent Inference Theory

575
Correspondent inference theory, proposed by Jones and Davis in 1965, seeks to explain how individuals infer stable personality traits from observed behaviors. It suggests that people attribute actions to underlying dispositions rather than external circumstances, particularly when the behavior appears intentional and socially significant.Voluntary Behavior and Dispositional AttributionAccording to this theory, individuals are more likely to attribute behavior to personal traits when it appears...
575
Setting Time of Cement01:12

Setting Time of Cement

689
The setting time of cement refers to the process of cement paste transitioning from a plastic state to a solid state. This process is crucial in construction as it dictates the timeframe for concrete placement, compaction, and finishing. The onset of this solidification is termed the initial set, indicating when the paste becomes unworkable. The final set is when the paste has solidified completely, and further handling or manipulation can no longer affect its shape. The cement strength is...
689

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Generalization of the Two Trials Paradigm.

Therapeutic innovation & regulatory science·2022
Same author

Replicability of studies following a dual-criterion design.

Statistics in medicine·2021
Same author

Subgroup identification in clinical trials via the predicted individual treatment effect.

PloS one·2018
Same author

Exploratory subgroup analysis in clinical trials by model selection.

Biometrical journal. Biometrische Zeitschrift·2016
Same author

Remarks on designs enriching for placebo non-responders.

Clinical trials (London, England)·2016
Same author

Analysis of cross-over studies with missing data.

Statistical methods in medical research·2014
Same journal

Understanding the Added Value of Action Limits for QTL Monitoring.

Therapeutic innovation & regulatory science·2026
Same journal

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same journal

Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context.

Therapeutic innovation & regulatory science·2026
Same journal

The Effect of Covariate Adjustment for Cox Regression in Cardiovascular Outcome Trials.

Therapeutic innovation & regulatory science·2026
Same journal

Current Status and Construction Requirements of Drug Clinical Trial Institutions in Sichuan Province in China.

Therapeutic innovation & regulatory science·2026
Same journal

The CARE Program: An Initiative of Patient-Focused Drug Development for Rare Diseases by NMPA.

Therapeutic innovation & regulatory science·2026
See all related articles

Related Experiment Video

Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Analysis Sets and Inference in Clinical Trials.

Gerd K Rosenkranz1

  • 11 Novartis Pharma AG, Basel, Switzerland.

Therapeutic Innovation & Regulatory Science
|September 22, 2018
PubMed
Summary
This summary is machine-generated.

The intention-to-treat (ITT) principle is standard for superiority trials but debated for noninferiority trials. This analysis suggests revising the International Conference on Harmonisation E9 guideline for more appropriate clinical trial data analysis.

Keywords:
analysis setscomplianceeffectivenessefficacy

More Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.8K

Related Experiment Videos

Last Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.8K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Regulatory Science

Background:

  • The intention-to-treat (ITT) principle is widely accepted for superiority clinical trials.
  • The optimal analysis strategy for noninferiority trials remains a subject of ongoing discussion.
  • Existing guidelines may not fully reflect current statistical methodologies.

Purpose of the Study:

  • To critically evaluate the established definitions of analysis sets in clinical trials.
  • To propose revisions to the International Conference on Harmonisation (ICH) E9 guideline regarding ITT and per-protocol analyses.
  • To advocate for more appropriate statistical analyses in noninferiority trials.

Main Methods:

  • Literature review of existing biostatistics guidelines and methodologies.
  • Analysis of the principles and application of intention-to-treat (ITT) and per-protocol analyses.
  • Discussion of the evolution of statistical methodology since the ICH E9 guideline issuance.

Main Results:

  • The current definitions of analysis sets may limit the appropriateness of trial data analysis.
  • The application of ITT and per-protocol principles requires re-evaluation for noninferiority contexts.
  • Advancement in statistical methods necessitates guideline updates.

Conclusions:

  • The International Conference on Harmonisation (ICH) E9 guideline concerning analysis sets requires revision.
  • Updated guidelines should accommodate modern statistical methodologies for more robust clinical trial analysis.
  • Revising the definitions and purpose of ITT and per-protocol analyses is crucial for noninferiority trials.